109 related articles for article (PubMed ID: 37728485)
1. Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Funauchi M; Serada S; Hiramatsu K; Funajima E; Kanda M; Nagase Y; Nakagawa S; Ohkawara T; Fujimoto M; Suzuki Y; Ueda Y; Kimura T; Naka T
Int J Cancer; 2024 Feb; 154(3):425-433. PubMed ID: 37728485
[TBL] [Abstract][Full Text] [Related]
2. Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer.
Kanda M; Serada S; Hiramatsu K; Funauchi M; Obata K; Nakagawa S; Ohkawara T; Murata O; Fujimoto M; Chiwaki F; Sasaki H; Ueda Y; Kimura T; Naka T
Neoplasia; 2023 Jan; 35():100853. PubMed ID: 36413881
[TBL] [Abstract][Full Text] [Related]
3. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y; Hiramatsu K; Funauchi M; Shiomi M; Masuda T; Kakuda M; Nakagawa S; Miyoshi A; Matsuzaki S; Kobayashi E; Kimura T; Serada S; Ueda Y; Naka T; Kimura T
BMC Cancer; 2022 Jun; 22(1):679. PubMed ID: 35729527
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
Miao G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
[TBL] [Abstract][Full Text] [Related]
5. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
[TBL] [Abstract][Full Text] [Related]
6. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.
Reaves DK; Fagan-Solis KD; Dunphy K; Oliver SD; Scott DW; Fleming JM
PLoS One; 2014; 9(3):e91747. PubMed ID: 24637461
[TBL] [Abstract][Full Text] [Related]
7. Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.
Fagan-Solis KD; Reaves DK; Rangel MC; Popoff MR; Stiles BG; Fleming JM
Mol Cancer; 2014 Jul; 13():163. PubMed ID: 24990559
[TBL] [Abstract][Full Text] [Related]
8. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice.
Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE
J Biol Chem; 2008 Sep; 283(37):25650-25659. PubMed ID: 18644789
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in regiospecific expression of Lipolysis Stimulated Receptor (LSR) in mice brain.
El Hajj A; Yen FT; Oster T; Malaplate C; Pauron L; Corbier C; Lanhers MC; Claudepierre T
PLoS One; 2019; 14(6):e0218812. PubMed ID: 31233547
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
[TBL] [Abstract][Full Text] [Related]
11. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Koh M; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanazaki K; Mori M; Doki Y; Naka T
Oncotarget; 2018 Aug; 9(68):32917-32928. PubMed ID: 30250639
[TBL] [Abstract][Full Text] [Related]
12. The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.
Shimada H; Satohisa S; Kohno T; Takahashi S; Hatakeyama T; Konno T; Tsujiwaki M; Saito T; Kojima T
Oncotarget; 2016 May; 7(19):27735-52. PubMed ID: 27036040
[TBL] [Abstract][Full Text] [Related]
13. Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells.
Czulkies BA; Mastroianni J; Lutz L; Lang S; Schwan C; Schmidt G; Lassmann S; Zeiser R; Aktories K; Papatheodorou P
Oncotarget; 2017 Jun; 8(23):37009-37022. PubMed ID: 27391068
[TBL] [Abstract][Full Text] [Related]
14. Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes.
Herzine A; Sekkat G; Kaminski S; Calcagno G; Boschi-Muller S; Safi H; Corbier C; Siest S; Claudepierre T; Yen FT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955777
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase.
Stenger C; Hanse M; Pratte D; Mbala ML; Akbar S; Koziel V; Escanyé MC; Kriem B; Malaplate-Armand C; Olivier JL; Oster T; Pillot T; Yen FT
FASEB J; 2010 Nov; 24(11):4218-28. PubMed ID: 20647547
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.
Knudson KM; Hicks KC; Alter S; Schlom J; Gameiro SR
J Immunother Cancer; 2019 Mar; 7(1):82. PubMed ID: 30898149
[TBL] [Abstract][Full Text] [Related]
17. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
[No Abstract] [Full Text] [Related]
18. LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
Takahashi Y; Serada S; Ohkawara T; Fujimoto M; Hiramatsu K; Ueda Y; Kimura T; Takemori H; Naka T
Biochem Biophys Res Commun; 2021 Jan; 537():93-99. PubMed ID: 33388415
[TBL] [Abstract][Full Text] [Related]
19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
20. Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line.
Kyuno T; Kyuno D; Kohno T; Konno T; Kikuchi S; Arimoto C; Yamaguchi H; Imamura M; Kimura Y; Kondoh M; Takemasa I; Kojima T
Histochem Cell Biol; 2020 Jan; 153(1):5-16. PubMed ID: 31650247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
